A 13-year-old client is prescribed atomoxetine. What is the expected therapeutic effect of this medication?

Rationale: A. Absence of Pain: Atomoxetine is a selective norepinephrine reuptake inhibitor used primarily for attention-deficit/hyperactivity disorder (ADHD). It does not have analgesic properties and is not indicated for pain management. B. Reduced Impulsivity: Atomoxetine increases norepinephrine levels in the prefrontal cortex, improving attention, focus, and executive function. This results in decreased hyperactivity and impulsivity in clients with ADHD, which is the primary therapeutic goal of the medication. C. Absence of Seizures: Atomoxetine is not an anticonvulsant and does not prevent or treat seizures. While rare seizure risk exists as an adverse effect, seizure control is not a therapeutic effect of this drug. D. Reduced Anxiety: Although some clients may experience secondary reductions in anxiety due to improved focus and control, atomoxetine is not primarily an anxiolytic and is not indicated for treating generalized anxiety or panic disorders.